Ready to help advance treatment for Alzheimer’s disease?
Ready to help advance treatment for Alzheimer’s disease?
Be part of the development of a new non-invasive wearable study device that delivers sensory stimulation and has the potential to slow the progression of mild to moderate Alzheimer’s disease, from the comfort of home.
“The HOPE Study offers a rare opportunity for patients with mild to moderate Alzheimer’s disease to participate in a research study utilizing technology as an intervention.
Our patients and families have expressed great interest in enrolling in this study because it is non-invasive and represents a novel and safe approach to potentially slowing the progression of Alzheimer’s disease.”
– Dr. Michelle Papka, Ph.D., Director and Founder of The Cognitive and Research Center of New Jersey
While many investigational drug treatments directly target widely known amyloid plaques and tau tangles in the brain, Cognito Therapeutics is investigating a unique, non-invasive medical device that targets other contributing factors to Alzheimer’s disease, such as the abnormal electrical activities in the brain.
This approach represents an opportunity to treat Alzheimer’s disease with a new modality and could bring much-needed treatment option to many impacted by this devastating disease.
The innovative medical device technology currently being evaluated in the HOPE Study emerged from a collaboration between two MIT neuroscientists and has been tested in multiple clinical studies to date.
In a 6-month long phase-2 study, treatment delivered through this investigational device has shown to significantly slow the progression of Alzheimer’s disease through preservation of cognitive and daily function, as well as whole brain volume among treated participants.
Patients across multiple clinical studies have completed over 40,000 treatment sessions to date and tolerated the study device well. No treatment limiting serious adverse events were reported.
– Phase 2 Trial Participant
Between 50 and 90 years of age
Have been diagnosed with Alzheimer’s disease by a healthcare professional
Have a reliable study partner, such as a family member or friend, who can help with participation in the study
Meet other criteria which will be evaluated
Additionally:
Participants who choose to enroll in the HOPE Study will:
No drugs or highly invasive procedures
No insurance or out-of-pocket payments necessary
Ready to help advance treatment for Alzheimer’s disease?